Dean Schorno
Financieel Directeur/CFO bij RIGEL PHARMACEUTICALS, INC.
Vermogen: 443 180 $ op 30-04-2024
Actieve functies van Dean Schorno
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| RIGEL PHARMACEUTICALS, INC. | Financieel Directeur/CFO | 29-05-2018 | - |
Loopbaan van Dean Schorno
Eerdere bekende functies van Dean Schorno
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
23andMe, Inc.
 23andMe, Inc. Medical SpecialtiesHealth Technology 23andMe, Inc. provides genetic information using DNA analysis technologies and web-based interactive tools. It enables individuals to gain deeper insights into personal ancestry, genealogy, and inherited traits. The company was founded by Linda Avey, Paul L. Cusenza and Anne E. Wojcicki in 2006 and is headquartered in Sunnyvale, CA. | Operationeel Directeur | 17-08-2015 | 01-05-2018 |
| Financieel Directeur/CFO | 17-08-2015 | 01-05-2018 | |
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | Financieel Directeur/CFO | 24-06-2014 | 10-08-2015 |
| GENOMIC HEALTH, INC. | Financieel Directeur/CFO | 10-01-2011 | 01-07-2014 |
| Investor Relations Contact | 01-07-2003 | 01-07-2014 | |
| Public Communications Contact | 01-07-2003 | 01-07-2014 | |
| Corporate Officer/Principal | 01-02-2010 | 10-01-2011 |
Opleiding van Dean Schorno
| University of California, Berkeley | Undergraduate Degree |
| Golden Gate University | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 7 |
Operationeel
| Director of Finance/CFO | 4 |
| Investor Relations Contact | 1 |
| Public Communications Contact | 1 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | Health Technology |
| RIGEL PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Genomic Health, Inc.
 Genomic Health, Inc. Medical SpecialtiesHealth Technology Genomic Health, Inc. engages in the provision of genomic-based diagnostic tests. Its tests analyze the underlying biology of cancers, allowing physicians and patients to make individualized treatment decisions. The firm uses a platform which translates a massive amount of clinical and genomic data into clinically actionable results for treatment planning. The company was founded by Patrick F. Terry, Joffre B. Baker, Randal W. Scott, and Steven Shak in August 2000 and is headquartered in Redwood City, CA. | Health Technology |
23andMe, Inc.
23andMe, Inc. Medical SpecialtiesHealth Technology 23andMe, Inc. provides genetic information using DNA analysis technologies and web-based interactive tools. It enables individuals to gain deeper insights into personal ancestry, genealogy, and inherited traits. The company was founded by Linda Avey, Paul L. Cusenza and Anne E. Wojcicki in 2006 and is headquartered in Sunnyvale, CA. | Health Technology |
- Beurs
- Insiders
- Dean Schorno
- Ervaring